Pierconti, Francesco
 Distribuzione geografica
Continente #
EU - Europa 2.789
NA - Nord America 2.766
AS - Asia 482
AF - Africa 22
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 6.085
Nazione #
US - Stati Uniti d'America 2.754
IT - Italia 732
SE - Svezia 626
DE - Germania 517
CN - Cina 330
PL - Polonia 279
UA - Ucraina 167
IE - Irlanda 142
FR - Francia 122
GB - Regno Unito 68
IN - India 54
FI - Finlandia 51
TR - Turchia 45
BE - Belgio 26
CI - Costa d'Avorio 16
IR - Iran 14
SG - Singapore 11
CA - Canada 10
NL - Olanda 9
CH - Svizzera 8
RU - Federazione Russa 8
ES - Italia 7
JP - Giappone 7
VN - Vietnam 7
AR - Argentina 5
AT - Austria 5
BR - Brasile 5
HK - Hong Kong 5
MA - Marocco 5
AU - Australia 4
NO - Norvegia 4
RO - Romania 4
EU - Europa 3
KR - Corea 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
MD - Moldavia 2
PA - Panama 2
PT - Portogallo 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CM - Camerun 1
DK - Danimarca 1
HR - Croazia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PK - Pakistan 1
TW - Taiwan 1
Totale 6.085
Città #
Chandler 570
Warsaw 266
Ashburn 236
Dublin 141
Ann Arbor 127
Fairfield 117
San Mateo 111
Jacksonville 104
Milan 104
Wilmington 104
Nanjing 93
Seattle 83
Rome 82
New York 78
Houston 68
Woodbridge 66
Dearborn 59
Princeton 52
Beijing 47
Boston 47
Chicago 46
Redmond 43
Izmir 41
Bremen 40
Marseille 34
Nanchang 34
Cattolica 31
Lawrence 28
Cambridge 26
Nürnberg 24
Brussels 22
Redwood City 21
Verona 21
Enterprise 18
Mountain View 18
Munich 18
Florence 17
Kunming 17
Los Angeles 17
Shenyang 17
Abidjan 16
Hangzhou 16
Naples 16
Helsinki 15
Tianjin 14
Falls Church 13
Hebei 13
Bologna 12
Jiaxing 12
Kraków 12
Bari 10
Augusta 9
Boardman 9
Genoa 9
Miami 9
Shanghai 9
Turin 8
Edinburgh 7
Fremont 7
Guangzhou 7
Lancaster 7
Norwalk 7
Palermo 7
Pune 7
Andover 6
Berlin 6
Changsha 6
Jinan 6
Kish 6
Orange 6
University Park 6
Washington 6
Changchun 5
Dong Ket 5
Gonzalez Catan 5
Gunzenhausen 5
Mumbai 5
Oujda 5
Vienna 5
Alba 4
Ardabil 4
Ferrara 4
Hong Kong 4
Hounslow 4
London 4
Madrid 4
Messina 4
Montanaso Lombardo 4
Philadelphia 4
Serracapriola 4
Tokyo 4
Treviso 4
Zhengzhou 4
Zurich 4
Amsterdam 3
Auburn Hills 3
Bern 3
Canberra 3
Chiampo 3
Chieti 3
Totale 3.500
Nome #
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 612
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 316
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 200
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 190
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 164
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 155
Incidental finding of right renal venous aneurysm in a patient with symptomatic ipsilateral renal carcinoma: a case report 143
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 134
MECKEL'S DIVERTICULUM FINDINGS ON TC-99 RED BLOOD SCINTIGRAPHY IN A BLEEDING LEUKEMIC PATIENT CONFIRMED BY TC-99 PERTENECHTATE SCINTIGRAPHY 122
Primary hepatic leiomyosarcoma in a young male after Hodgkin s disease: diagnostic pitfalls and therapeutic challenge 113
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 111
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 109
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 106
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 106
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 101
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 99
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 95
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 93
Metabolic reprogramming by malat1 depletion in prostate cancer 93
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 85
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 81
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 79
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 79
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 77
Paraneoplastic Hyperinsulinism due to Renal Cell Carcinoma Treated With Robotic Nephrectomy 70
Bladder and prostate metastasis from small cell lung cancer: a rare entity 70
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 69
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 68
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 68
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 68
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 66
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 66
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 66
Olfactory receptors in semen and in the male tract: From proteome to proteins 64
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 62
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 61
Giant spermatic cord liposarcoma 57
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 57
Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology 56
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 56
Cytological and histological changes in the urothelium produced by electromotive drug administration (EMDA) and by the combination of intravescical hyperthermia and chemotherapy (thermochemotherapy) 56
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 56
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. 55
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 53
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 53
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 52
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 51
Proteomics for the identification of biomarkers in testicular cancer–review 51
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 50
Methylation study of the Paris system for reporting urinary (TPS) categories 50
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making 49
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 48
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 48
Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? 48
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 48
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 48
Biomarkers of response to advanced prostate cancer therapy 48
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 47
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 45
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 45
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 44
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 44
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 44
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 43
Mesenchymal differentiation of glioblastoma stem cells 42
Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario. 42
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 42
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 36
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma. 35
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 29
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 29
Mesenchymal differentiation of glioblastoma stem cells 27
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 26
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 26
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders 24
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base: Technical note 23
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 22
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 19
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 19
Extremely delayed falx metastasis from renal cell carcinoma 18
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma 17
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 16
Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine 13
Bladder cancer in the time of machine learning: Intelligent tools for diagnosis and management 12
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 10
Male sling placement for post-prostatectomy incontinence can involve a lengthy learning curve: A multi-outcome assessment via cumulative sum failure analysis 9
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 9
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching 8
Metastasis to the renal hilum from malignant melanoma of the anterior trunk: An unusual finding 8
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes 7
p53 expression in cytology samples may represent a marker of early-stage cancer 7
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma 4
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological Centre 3
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 2
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 2
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 1
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy 1
First-line ICIs in renal cell carcinoma 1
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B-cell lymphoma: A case report 1
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 1
Totale 6.254
Categoria #
all - tutte 22.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.947


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019106 0 0 0 0 0 0 0 0 0 0 69 37
2019/2020826 128 66 50 64 45 63 80 36 67 32 129 66
2020/2021760 85 113 56 56 80 58 47 13 68 43 123 18
2021/2022860 76 39 27 80 70 28 38 125 41 57 131 148
2022/20231.769 249 232 139 261 92 210 84 130 179 69 83 41
2023/2024954 79 227 62 75 89 158 93 61 24 84 2 0
Totale 6.255